CureDuchenne

CureDuchenne

CureDuchenne is a grassroots effort to bring back focus and are a not for profit making organization. CureDuchenne was started by parents whose only child has DMD.

Their efforts are targeted. They have leading world scientists helping to determine the most viable research projects…and moreover… to accelerate the clinical trial process and bring potential life saving drugs to help this generation of Duchenne boys.


Website www.cureduchenne.org

 

Debra Miller Debra Miller

Debra Miller co-founded CureDuchenne in 2003 with her husband, Paul, after their only son was diagnosed with Duchenne.  Miller relies on her extensive background in sales and marketing to lead CureDuchenne.  

More Info

 

Michael  Kelly Michael Kelly

Michael Kelly has more than 25 years of experience in drug discovery and development organizations. He is currently the chief scientific officer of CureDuchenne. Prior to that, Mike served as president and U.S. site head of Renovis, Inc., and held positions at Amgen, Wyeth (Pfizer) and Wellcome (GSK) among others. Mike received his Ph.D. from the University of Southampton, and held research positions at the University of Michigan and University of Nottingham; he is an inventor on more than 100 patents and is widely published in peer reviewed journals.

More Info